Innovations

Innovation

LIGHTS UP THE BEAUTY OF LIFE

The company has embraced an innovation-driven strategy, and it has continuously enhanced its R&D capabilities in recent years. It has built multiple core technology platforms covering cutting-edge fields such as RNAi therapeutics, radionuclide drug conjugates (RDC), FIC & BIC antibodies, recombinant drugs, and innovative small-molecule drugs etc.

15 %+

Proportion of average R&D investment

300 +

On-going research projects (incl. both innovative and high-value projects)

1200 +

Professionals in R&D and Clinical Medicine

50 %+

Proportion of R&D team with master and PhD

Four R&D Directions

Characteristic API
High-end generic drugs
Innovative drugs
Novel drug delivery system

Focused Disease Areas

Oncology
Immunology & Inflammation
Cardiovascular & Metabolic Diseases
Respiratory & Anti-infective
Neurology & Psychiatry
Rare diseases and others

Key R&D Institutions

Pharmaceutical Research Institute
Purity Research Institute
ScinnoHub Pharmaceuticals
Shanghai Hongcheng Biopharma
Brilliant Harpoon Biotechnology
Haihe Pharmaceuticals
Suvanta Pharma

R&D Innovation Features

Differentiated Pipelines
International R&D Team
Scientific and Precise Project Initiations
Diversified Cooperation Models

Four R&D Directions

Characteristic API

High-end generic drugs

Innovative drugs

Novel drug delivery system

Focused Disease Areas

Oncology

Immunology & Inflammation

Cardiovascular & Metabolic Diseases

Respiratory & Anti-infective

Neurology & Psychiatry

Rare diseases and others

Key R&D Institutions

Pharmaceutical Research Institute

Purity Research Institute

ScinnoHub Pharmaceuticals

Shanghai Hongcheng Biopharma

Brilliant Harpoon Biotechnology

Haihe Pharmaceuticals

Suvanta Pharma

R&D Innovation Features

Differentiated Pipelines

International R&D Team

Scientific and Precise Project Initiations

Diversified Cooperation Models

Technology Platforms

RNAi therapeutics

RDC development

Recombinant drug development

Topical formulations

FIC&BIC antibodies

Small-molecule innovation

Inhaled formulations & Novel delivery

Novel Drug Delivery System(NDDS)

Cell & gene therapeutics

Innovative Chinese patent medicine

R&D Institutions

Pharmaceutical Research Institute

Purity Research Institute

ScinnoHub Pharmaceuticals

Shanghai Hongcheng Biopharma

Brilliant Harpoon Biotechnology

Haihe Pharmaceuticals

Suvanta Pharma Inc.

R&D Talents

The company values the introduction and cultivation of innovative talent, has a well-established talent incentive mechanism, and integrates talent development with its strategic direction in science and technology to enable them to fully exercise their innovative abilities and meet the needs of the company, the industry, and society

Intellectual Property

850 +

Patent Applications

300 +

Domestic Authorized Patents

200 +

Overseas Patent Applications

20 +

Overseas Authorized Patents